Evidence map›Paper›PMID 39465454›Full record

ReviewDrugs & aging2024

Pharmacological Pain Treatment in Older Persons.

Gisèle Pickering, Aleksandra Kotlińska-Lemieszek, Nevenka Krcevski Skvarc, Denis O'Mahony, Fiammetta Monacelli, Roger Knaggs, Véronique Morel, Magdalena Kocot-Kępska

Abstract readReview
In one paragraph

Review in Drugs & aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Guideline
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The Thai ICOAP-Hip: Cross-Cultural Adaptation and Validation for Assessing Intermittent and Constant Pain in Hip Osteoarthritis.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gisèle PickeringClinical Pharmacology Department, PIC/CIC Inserm 1405-University Hospital CHU and Faculty of Medicine, Université Clermont Auvergne, Clermont-Ferrand, France. gisele.pickering@uca.fr.
Aleksandra Kotlińska-LemieszekDepartment of Palliative Medicine, Pharmacotherapy in Palliative Care Laboratory, Poznan University of Medical Sciences, Poznań, Poland.
Nevenka Krcevski SkvarcInstitute for Palliative Medicine and Care, Faculty of Medicine of University Maribor, Maribor, Slovenia.
Denis O'MahonyDepartment of Medicine, University College Cork, Cork University Hospital, Cork, Ireland.
Fiammetta MonacelliDIMI, University of Genoa, Viale Benedetto XV, Genoa, Italy.
Roger KnaggsUniversity of Nottingham, University Park, Nottingham, UK.
Véronique MorelClinical Pharmacology Department, PIC/CIC Inserm 1405-University Hospital CHU and Faculty of Medicine, Université Clermont Auvergne, Clermont-Ferrand, France.
Magdalena Kocot-KępskaDepartment for Pain Research and Treatment, Medical College Jagiellonian University, Krakow, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmacological pain treatment in older persons is presented by a multi-disciplinary group of European pain experts. Drugs recommended for acute or chronic nociceptive pain, also for neuropathic pain and the routes of administration of choice are the same as those prescribed for younger persons but comorbidities and polypharmacy in older persons increase the risk of adverse effects and drug interactions. Not all drugs are available or authorised in all European countries. For mild-to-moderate pain, non-opioids including paracetamol and non-steroidal anti-inflammatory drugs are first-line treatments, followed by nefopam and metamizole. Codeine, dihydrocodeine and tramadol are prescribed for moderate to severe pain and 'strong' opioids, including morphine, hydromorphone, oxycodone, fentanyl, buprenorphine, methadone and tapentadol, for severe pain. Chronic neuropathic pain treatment relies on coanalgesics, including anti-epileptics (gabapentinoids) and anti-depressants with additional option of topical lidocaine and capsaicine. The choice of analgesic(s) and the route of administration should be guided by the pain characteristics, as well as by the patient's comorbidities, organ function and medications. Several directions have been highlighted to optimise pharmacological pain management in older individuals: (1) before starting pain treatment adequately detect and assess pain and always perform a full geriatric assessment, (2) consider kidney function systematically to adjust the doses of analgesics and avoid the risks of overdose, (3) start with the lowest dose of an analgesic and increase it gradually under the control of the effect, (4) involve the older persons and family in their treatment, (5) reevaluate pain regularly during treatment and (6) combine pharmacological treatment with non-pharmacological approaches.

Indexed as

AnalgesicsPain ManagementAgedHumansNeuralgiaPainAnalgesics

Identifiers

PMID39465454
PMCPMC11634925

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.